MedImmune: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity, of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically......

Project: Research

Status	Finished
Effective start/end date	09/23/08 → 05/14/10

Project Details